Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU6F2
|
ENSG00000106536.15 | POU class 6 homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU6F2 | hg19_v2_chr7_+_39125365_39125489 | 0.46 | 7.6e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_73038822 | 4.57 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
chrX_+_43515467 | 4.43 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chr7_-_73038867 | 4.36 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
chr8_+_92261516 | 4.35 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
chr2_-_217560248 | 3.92 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr10_-_128210005 | 3.60 |
ENST00000284694.7
ENST00000454341.1 ENST00000432642.1 ENST00000392694.1 |
C10orf90
|
chromosome 10 open reading frame 90 |
chr15_-_54025300 | 3.41 |
ENST00000559418.1
|
WDR72
|
WD repeat domain 72 |
chr20_+_56136136 | 3.29 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr3_+_159557637 | 3.25 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr12_-_16758835 | 3.21 |
ENST00000541295.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr12_-_103344615 | 3.20 |
ENST00000546844.1
|
PAH
|
phenylalanine hydroxylase |
chr12_-_16758873 | 3.18 |
ENST00000535535.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr21_+_17442799 | 3.05 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr12_-_16762802 | 3.04 |
ENST00000534946.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr2_-_217559517 | 2.98 |
ENST00000449583.1
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr11_-_82444892 | 2.89 |
ENST00000329203.3
|
FAM181B
|
family with sequence similarity 181, member B |
chr12_-_16759440 | 2.87 |
ENST00000537304.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chrX_-_18690210 | 2.83 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
chr6_-_100912785 | 2.59 |
ENST00000369208.3
|
SIM1
|
single-minded family bHLH transcription factor 1 |
chr3_+_35685113 | 2.58 |
ENST00000419330.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr17_-_10421853 | 2.51 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
chr20_+_42187682 | 2.48 |
ENST00000373092.3
ENST00000373077.1 |
SGK2
|
serum/glucocorticoid regulated kinase 2 |
chr11_-_26593649 | 2.46 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
chr17_+_37784749 | 2.43 |
ENST00000394265.1
ENST00000394267.2 |
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr12_-_87232644 | 2.40 |
ENST00000549405.2
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr11_+_107461804 | 2.30 |
ENST00000531234.1
|
ELMOD1
|
ELMO/CED-12 domain containing 1 |
chr5_-_96478466 | 2.24 |
ENST00000274382.4
|
LIX1
|
Lix1 homolog (chicken) |
chr11_-_26593779 | 2.22 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
chr11_-_70672645 | 2.14 |
ENST00000423696.2
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
chr6_-_87804815 | 2.13 |
ENST00000369582.2
|
CGA
|
glycoprotein hormones, alpha polypeptide |
chr12_-_16762971 | 2.03 |
ENST00000540590.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr5_-_36301984 | 1.96 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
chr1_-_234667504 | 1.96 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
chr11_-_27494309 | 1.94 |
ENST00000389858.4
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4 |
chr6_+_151646800 | 1.93 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr11_-_129062093 | 1.93 |
ENST00000310343.9
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr11_-_26593677 | 1.92 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
chr20_+_42187608 | 1.92 |
ENST00000373100.1
|
SGK2
|
serum/glucocorticoid regulated kinase 2 |
chr3_+_147657764 | 1.83 |
ENST00000467198.1
ENST00000485006.1 |
RP11-71N10.1
|
RP11-71N10.1 |
chrX_-_13835147 | 1.81 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
chr11_+_125034586 | 1.79 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
chr11_+_45918092 | 1.78 |
ENST00000395629.2
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1 |
chr11_+_65554493 | 1.69 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
chr12_-_100378006 | 1.65 |
ENST00000547776.2
ENST00000329257.7 ENST00000547010.1 |
ANKS1B
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr11_-_27494279 | 1.63 |
ENST00000379214.4
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4 |
chr14_+_32798547 | 1.62 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr14_+_32798462 | 1.59 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
chr21_-_31864275 | 1.58 |
ENST00000334063.4
|
KRTAP19-3
|
keratin associated protein 19-3 |
chr1_-_31666767 | 1.56 |
ENST00000530145.1
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
chr11_-_93583697 | 1.52 |
ENST00000409977.1
|
VSTM5
|
V-set and transmembrane domain containing 5 |
chr1_+_31883048 | 1.51 |
ENST00000536859.1
|
SERINC2
|
serine incorporator 2 |
chr13_-_44735393 | 1.49 |
ENST00000400419.1
|
SMIM2
|
small integral membrane protein 2 |
chr9_+_109625378 | 1.48 |
ENST00000277225.5
ENST00000457913.1 ENST00000472574.1 |
ZNF462
|
zinc finger protein 462 |
chr4_+_110749143 | 1.48 |
ENST00000317735.4
|
RRH
|
retinal pigment epithelium-derived rhodopsin homolog |
chr5_-_96478457 | 1.47 |
ENST00000512378.1
|
LIX1
|
Lix1 homolog (chicken) |
chr3_+_111717511 | 1.45 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr12_-_16761007 | 1.43 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr12_-_71031185 | 1.42 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr8_-_37189432 | 1.39 |
ENST00000518765.1
|
RP11-527N22.1
|
RP11-527N22.1 |
chr14_-_27066960 | 1.37 |
ENST00000539517.2
|
NOVA1
|
neuro-oncological ventral antigen 1 |
chr5_+_125706998 | 1.35 |
ENST00000506445.1
|
GRAMD3
|
GRAM domain containing 3 |
chr3_+_111717600 | 1.34 |
ENST00000273368.4
|
TAGLN3
|
transgelin 3 |
chr2_+_44502597 | 1.34 |
ENST00000260649.6
ENST00000409387.1 |
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1 |
chr2_+_7118755 | 1.33 |
ENST00000433456.1
|
RNF144A
|
ring finger protein 144A |
chr4_+_110834033 | 1.32 |
ENST00000509793.1
ENST00000265171.5 |
EGF
|
epidermal growth factor |
chr15_+_67390920 | 1.31 |
ENST00000559092.1
ENST00000560175.1 |
SMAD3
|
SMAD family member 3 |
chr9_-_13165457 | 1.30 |
ENST00000542239.1
ENST00000538841.1 ENST00000433359.2 |
MPDZ
|
multiple PDZ domain protein |
chr1_-_159832438 | 1.27 |
ENST00000368100.1
|
VSIG8
|
V-set and immunoglobulin domain containing 8 |
chr8_+_77593474 | 1.24 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
chr12_-_16761117 | 1.23 |
ENST00000538051.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr3_+_111718036 | 1.22 |
ENST00000455401.2
|
TAGLN3
|
transgelin 3 |
chr7_+_5465382 | 1.22 |
ENST00000609130.1
|
RP11-1275H24.2
|
RP11-1275H24.2 |
chr1_-_204329013 | 1.22 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
chr4_+_66536248 | 1.19 |
ENST00000514260.1
ENST00000507117.1 |
RP11-807H7.1
|
RP11-807H7.1 |
chr13_+_58206655 | 1.19 |
ENST00000377918.3
|
PCDH17
|
protocadherin 17 |
chr22_+_30792846 | 1.18 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
chr14_-_36989336 | 1.15 |
ENST00000522719.2
|
NKX2-1
|
NK2 homeobox 1 |
chr3_+_189507523 | 1.15 |
ENST00000437221.1
ENST00000392463.2 ENST00000392461.3 ENST00000449992.1 ENST00000456148.1 |
TP63
|
tumor protein p63 |
chr11_-_102709441 | 1.15 |
ENST00000434103.1
|
MMP3
|
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
chr21_-_42219065 | 1.11 |
ENST00000400454.1
|
DSCAM
|
Down syndrome cell adhesion molecule |
chr17_-_10372875 | 1.11 |
ENST00000255381.2
|
MYH4
|
myosin, heavy chain 4, skeletal muscle |
chr2_+_44502630 | 1.08 |
ENST00000410056.3
ENST00000409741.1 ENST00000409229.3 |
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1 |
chr21_+_33671160 | 1.08 |
ENST00000303645.5
|
MRAP
|
melanocortin 2 receptor accessory protein |
chr2_+_35056422 | 1.07 |
ENST00000592523.1
ENST00000588944.1 ENST00000585391.1 ENST00000591221.1 ENST00000586769.1 ENST00000588650.1 |
AC012593.1
|
AC012593.1 |
chr8_-_142012169 | 1.06 |
ENST00000517453.1
|
PTK2
|
protein tyrosine kinase 2 |
chrX_+_86772707 | 1.05 |
ENST00000373119.4
|
KLHL4
|
kelch-like family member 4 |
chr1_+_50571949 | 1.03 |
ENST00000357083.4
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr12_-_86230315 | 1.01 |
ENST00000361228.3
|
RASSF9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
chr18_-_24129367 | 1.01 |
ENST00000408011.3
|
KCTD1
|
potassium channel tetramerization domain containing 1 |
chr14_-_36988882 | 1.01 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr8_+_77593448 | 1.00 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr3_-_127541194 | 1.00 |
ENST00000453507.2
|
MGLL
|
monoglyceride lipase |
chr1_+_175036966 | 0.99 |
ENST00000239462.4
|
TNN
|
tenascin N |
chr9_-_79520989 | 0.98 |
ENST00000376713.3
ENST00000376718.3 ENST00000428286.1 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr1_-_153123345 | 0.98 |
ENST00000368748.4
|
SPRR2G
|
small proline-rich protein 2G |
chr11_-_36619771 | 0.98 |
ENST00000311485.3
ENST00000527033.1 ENST00000532616.1 |
RAG2
|
recombination activating gene 2 |
chr12_-_71031220 | 0.96 |
ENST00000334414.6
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr6_+_25754927 | 0.95 |
ENST00000377905.4
ENST00000439485.2 |
SLC17A4
|
solute carrier family 17, member 4 |
chr7_-_16840820 | 0.95 |
ENST00000450569.1
|
AGR2
|
anterior gradient 2 |
chr7_+_6655225 | 0.94 |
ENST00000457543.3
|
ZNF853
|
zinc finger protein 853 |
chr6_+_42123141 | 0.94 |
ENST00000418175.1
ENST00000541991.1 ENST00000053469.4 ENST00000394237.1 ENST00000372963.1 |
GUCA1A
RP1-139D8.6
|
guanylate cyclase activator 1A (retina) RP1-139D8.6 |
chr6_+_50786414 | 0.94 |
ENST00000344788.3
ENST00000393655.3 ENST00000263046.4 |
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
chr1_+_107683644 | 0.93 |
ENST00000370067.1
|
NTNG1
|
netrin G1 |
chr4_+_88571429 | 0.92 |
ENST00000339673.6
ENST00000282479.7 |
DMP1
|
dentin matrix acidic phosphoprotein 1 |
chr3_+_111718173 | 0.91 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr1_-_182641037 | 0.90 |
ENST00000483095.2
|
RGS8
|
regulator of G-protein signaling 8 |
chr2_-_105030466 | 0.90 |
ENST00000449772.1
|
AC068535.3
|
AC068535.3 |
chr7_-_14029283 | 0.89 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
chr3_-_33686925 | 0.88 |
ENST00000485378.2
ENST00000313350.6 ENST00000487200.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr21_+_17443521 | 0.87 |
ENST00000456342.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr17_-_39553844 | 0.87 |
ENST00000251645.2
|
KRT31
|
keratin 31 |
chrX_+_86772787 | 0.86 |
ENST00000373114.4
|
KLHL4
|
kelch-like family member 4 |
chr5_+_126984710 | 0.86 |
ENST00000379445.3
|
CTXN3
|
cortexin 3 |
chr6_+_4087664 | 0.86 |
ENST00000430835.2
|
C6orf201
|
chromosome 6 open reading frame 201 |
chr7_-_14028488 | 0.85 |
ENST00000405358.4
|
ETV1
|
ets variant 1 |
chr8_-_10512569 | 0.84 |
ENST00000382483.3
|
RP1L1
|
retinitis pigmentosa 1-like 1 |
chr4_-_66536196 | 0.84 |
ENST00000511294.1
|
EPHA5
|
EPH receptor A5 |
chr9_+_130853715 | 0.84 |
ENST00000373066.5
ENST00000432073.2 |
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr5_+_159343688 | 0.80 |
ENST00000306675.3
|
ADRA1B
|
adrenoceptor alpha 1B |
chr5_-_124082279 | 0.80 |
ENST00000513986.1
|
ZNF608
|
zinc finger protein 608 |
chr15_-_37393406 | 0.80 |
ENST00000338564.5
ENST00000558313.1 ENST00000340545.5 |
MEIS2
|
Meis homeobox 2 |
chrX_-_151619746 | 0.77 |
ENST00000370314.4
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
chr4_-_22444733 | 0.76 |
ENST00000508133.1
|
GPR125
|
G protein-coupled receptor 125 |
chr8_-_42358742 | 0.74 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr17_-_29624343 | 0.74 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
chr12_-_15815626 | 0.74 |
ENST00000540613.1
|
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr3_-_51909600 | 0.74 |
ENST00000446461.1
|
IQCF5
|
IQ motif containing F5 |
chr5_-_156486120 | 0.73 |
ENST00000522693.1
|
HAVCR1
|
hepatitis A virus cellular receptor 1 |
chr3_+_189507460 | 0.72 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
chr8_-_42396185 | 0.70 |
ENST00000518717.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr7_+_129007964 | 0.69 |
ENST00000460109.1
ENST00000474594.1 ENST00000446212.1 |
AHCYL2
|
adenosylhomocysteinase-like 2 |
chr1_-_208417620 | 0.69 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
chr15_-_33447055 | 0.67 |
ENST00000559047.1
ENST00000561249.1 |
FMN1
|
formin 1 |
chr15_+_96869165 | 0.67 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr22_+_20905269 | 0.66 |
ENST00000457322.1
|
MED15
|
mediator complex subunit 15 |
chr15_-_88247083 | 0.66 |
ENST00000560439.1
|
RP11-648K4.2
|
RP11-648K4.2 |
chr21_+_17443434 | 0.66 |
ENST00000400178.2
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr15_+_58702742 | 0.65 |
ENST00000356113.6
ENST00000414170.3 |
LIPC
|
lipase, hepatic |
chr1_+_50574585 | 0.65 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr8_+_42396274 | 0.63 |
ENST00000438528.3
|
SMIM19
|
small integral membrane protein 19 |
chr1_+_10271674 | 0.63 |
ENST00000377086.1
|
KIF1B
|
kinesin family member 1B |
chr1_+_107683436 | 0.62 |
ENST00000370068.1
|
NTNG1
|
netrin G1 |
chr1_-_182640988 | 0.61 |
ENST00000367556.1
|
RGS8
|
regulator of G-protein signaling 8 |
chr12_-_131118370 | 0.57 |
ENST00000541840.1
|
RP11-662M24.2
|
RP11-662M24.2 |
chr19_-_28957557 | 0.57 |
ENST00000585697.1
ENST00000591920.1 |
AC005307.3
|
AC005307.3 |
chr2_+_102721023 | 0.55 |
ENST00000409589.1
ENST00000409329.1 |
IL1R1
|
interleukin 1 receptor, type I |
chr8_+_39792474 | 0.55 |
ENST00000502986.2
|
IDO2
|
indoleamine 2,3-dioxygenase 2 |
chr8_-_42234745 | 0.55 |
ENST00000220812.2
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4 |
chr3_+_189507432 | 0.55 |
ENST00000354600.5
|
TP63
|
tumor protein p63 |
chrX_-_23926004 | 0.55 |
ENST00000379226.4
ENST00000379220.3 |
APOO
|
apolipoprotein O |
chr6_-_138866823 | 0.54 |
ENST00000342260.5
|
NHSL1
|
NHS-like 1 |
chr16_-_54962415 | 0.54 |
ENST00000501177.3
ENST00000559598.2 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
chr15_+_101402041 | 0.54 |
ENST00000558475.1
ENST00000558641.1 ENST00000559673.1 |
RP11-66B24.1
|
RP11-66B24.1 |
chr17_-_33390667 | 0.54 |
ENST00000378516.2
ENST00000268850.7 ENST00000394597.2 |
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
chr22_-_32767017 | 0.52 |
ENST00000400234.1
|
RFPL3S
|
RFPL3 antisense |
chr10_-_23633720 | 0.50 |
ENST00000323327.4
|
C10orf67
|
chromosome 10 open reading frame 67 |
chr11_+_101918153 | 0.49 |
ENST00000434758.2
ENST00000526781.1 ENST00000534360.1 |
C11orf70
|
chromosome 11 open reading frame 70 |
chr2_+_128403720 | 0.49 |
ENST00000272644.3
|
GPR17
|
G protein-coupled receptor 17 |
chr5_+_36606700 | 0.49 |
ENST00000416645.2
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr5_-_139726181 | 0.47 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr3_+_2553281 | 0.47 |
ENST00000434053.1
|
CNTN4
|
contactin 4 |
chr10_-_102989551 | 0.45 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
chr2_-_80531824 | 0.44 |
ENST00000295057.3
|
LRRTM1
|
leucine rich repeat transmembrane neuronal 1 |
chr22_+_20905422 | 0.43 |
ENST00000424287.1
ENST00000423862.1 |
MED15
|
mediator complex subunit 15 |
chr6_-_33160231 | 0.43 |
ENST00000395194.1
ENST00000457788.1 ENST00000341947.2 ENST00000357486.1 ENST00000374714.1 ENST00000374713.1 ENST00000395197.1 ENST00000374712.1 ENST00000361917.1 ENST00000374708.4 |
COL11A2
|
collagen, type XI, alpha 2 |
chr3_+_193809263 | 0.42 |
ENST00000457815.1
|
RP11-135A1.3
|
RP11-135A1.3 |
chr11_-_71823715 | 0.40 |
ENST00000545944.1
ENST00000502597.2 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr1_+_19967014 | 0.38 |
ENST00000428975.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr21_-_31971219 | 0.37 |
ENST00000334897.3
|
KRTAP6-2
|
keratin associated protein 6-2 |
chr6_+_76330355 | 0.36 |
ENST00000483859.2
|
SENP6
|
SUMO1/sentrin specific peptidase 6 |
chr7_+_129015484 | 0.36 |
ENST00000490911.1
|
AHCYL2
|
adenosylhomocysteinase-like 2 |
chrX_+_99839799 | 0.35 |
ENST00000373031.4
|
TNMD
|
tenomodulin |
chr13_-_110438914 | 0.33 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chrX_+_3189861 | 0.32 |
ENST00000457435.1
ENST00000420429.2 |
CXorf28
|
chromosome X open reading frame 28 |
chr11_-_71823796 | 0.31 |
ENST00000545680.1
ENST00000543587.1 ENST00000538393.1 ENST00000535234.1 ENST00000227618.4 ENST00000535503.1 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr2_+_138721850 | 0.29 |
ENST00000329366.4
ENST00000280097.3 |
HNMT
|
histamine N-methyltransferase |
chr5_-_134914673 | 0.29 |
ENST00000512158.1
|
CXCL14
|
chemokine (C-X-C motif) ligand 14 |
chr4_-_66536057 | 0.29 |
ENST00000273854.3
|
EPHA5
|
EPH receptor A5 |
chr2_+_29001711 | 0.28 |
ENST00000418910.1
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme |
chr12_-_24097236 | 0.28 |
ENST00000538083.1
|
SOX5
|
SRY (sex determining region Y)-box 5 |
chr3_+_77088989 | 0.27 |
ENST00000461745.1
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
chr3_-_57199397 | 0.27 |
ENST00000296318.7
|
IL17RD
|
interleukin 17 receptor D |
chr2_-_216003127 | 0.25 |
ENST00000412081.1
ENST00000272895.7 |
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr1_-_47655686 | 0.24 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr2_-_80531399 | 0.23 |
ENST00000409148.1
ENST00000415098.1 ENST00000452811.1 |
LRRTM1
|
leucine rich repeat transmembrane neuronal 1 |
chr7_+_116660246 | 0.23 |
ENST00000434836.1
ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7
|
suppression of tumorigenicity 7 |
chr1_-_201140673 | 0.23 |
ENST00000367333.2
|
TMEM9
|
transmembrane protein 9 |
chr1_+_61869748 | 0.20 |
ENST00000357977.5
|
NFIA
|
nuclear factor I/A |
chr2_+_128403439 | 0.20 |
ENST00000544369.1
|
GPR17
|
G protein-coupled receptor 17 |
chr7_+_129015671 | 0.20 |
ENST00000466993.1
|
AHCYL2
|
adenosylhomocysteinase-like 2 |
chrX_-_106243451 | 0.19 |
ENST00000355610.4
ENST00000535534.1 |
MORC4
|
MORC family CW-type zinc finger 4 |
chr5_+_115177178 | 0.19 |
ENST00000316788.7
|
AP3S1
|
adaptor-related protein complex 3, sigma 1 subunit |
chr2_-_80531720 | 0.18 |
ENST00000416268.1
|
LRRTM1
|
leucine rich repeat transmembrane neuronal 1 |
chr6_-_155635583 | 0.18 |
ENST00000367166.4
|
TFB1M
|
transcription factor B1, mitochondrial |
chr4_-_74486347 | 0.17 |
ENST00000342081.3
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr18_+_44812072 | 0.17 |
ENST00000598649.1
ENST00000586905.2 |
CTD-2130O13.1
|
CTD-2130O13.1 |
chr9_-_21482312 | 0.16 |
ENST00000448696.3
|
IFNE
|
interferon, epsilon |
chr6_+_151042224 | 0.16 |
ENST00000358517.2
|
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
chr15_+_74421961 | 0.15 |
ENST00000565159.1
ENST00000567206.1 |
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
chr7_+_148287657 | 0.15 |
ENST00000307003.2
|
C7orf33
|
chromosome 7 open reading frame 33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.9 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.2 | 17.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.9 | 3.6 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.8 | 3.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.7 | 8.9 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.7 | 2.8 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.6 | 2.4 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.4 | 3.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.4 | 1.2 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.3 | 1.7 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 2.4 | GO:0015811 | L-cystine transport(GO:0015811) |
0.3 | 1.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 4.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 1.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 2.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 4.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 4.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 1.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 2.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 0.7 | GO:0009956 | radial pattern formation(GO:0009956) |
0.2 | 1.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 3.2 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.6 | GO:1904647 | response to rotenone(GO:1904647) |
0.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.9 | GO:1903899 | lung goblet cell differentiation(GO:0060480) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.9 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 1.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.1 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 1.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 1.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 2.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 1.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 2.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.5 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 3.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 6.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.4 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.0 | 0.3 | GO:0061364 | negative regulation of negative chemotaxis(GO:0050925) apoptotic process involved in luteolysis(GO:0061364) |
0.0 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.6 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.3 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 4.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 1.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 1.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 2.6 | GO:0001657 | ureteric bud development(GO:0001657) |
0.0 | 1.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 2.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.1 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 1.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 1.1 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 1.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.2 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 2.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.8 | GO:0008542 | visual learning(GO:0008542) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.5 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.2 | 3.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 2.1 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 3.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 8.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 1.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 4.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 1.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 2.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 2.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 2.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 4.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 4.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 1.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 3.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 6.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 4.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 2.4 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.4 | 1.1 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.3 | 2.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.3 | 1.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.3 | 0.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 5.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 4.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 1.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 2.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 2.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.6 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 0.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 4.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.9 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.1 | 2.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.3 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 3.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 10.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 1.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 1.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 5.8 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 4.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.7 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.6 | GO:0051117 | ATPase binding(GO:0051117) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 3.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 10.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 2.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 2.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 3.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 4.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 2.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 6.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 8.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 2.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 7.8 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 3.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |